Correction to: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study (Cardio-Oncology, (2024), 10, 1, (3), 10.1186/s40959-023-00191-0)

Jian Chu; Lillian Tung; Issam Atallah; Changli Wei; Melody Cobleigh; Ruta Rao; Steven B. Feinstein; Lydia Usha; Kathrin Banach; Jochen Reiser; Tochukwu M. Okwuosa

doi:10.1186/s40959-024-00205-5

Correction to: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study (Cardio-Oncology, (2024), 10, 1, (3), 10.1186/s40959-023-00191-0)

Jian Chu
, Lillian Tung
, Issam Atallah
, Changli Wei
, Melody Cobleigh
, Ruta Rao
, Steven B. Feinstein
, Lydia Usha
, Kathrin Banach
, Jochen Reiser
, Tochukwu M. Okwuosa

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

BioMed Central 1 5 0 2024 BioMed Central Ltd., part of Springer Nature 2024 No Unnumbered 2024 1 25 0 0 Regular ArchiveJournal Unnumbered OpenChoice OpenAccess OpenAccess OpenAccess OpenAccess OpenAccess OpenAccess false BodyRef/PDF/40959_2024_Article_205.pdf All Typeset OnlinePDF Regular Erratum Medicine & Public Health Oncology Cardiology Medicine true Following publication of the original article [1], the authors identified an error in the author name of Issam Atallah. The incorrect author name is: Issam Attalah. The correct author name is: Issam Atallah. The author group has been updated above and the original article [1] has been corrected.

Original language	English (US)
Pages (from-to)	5
Journal	Cardio-Oncology
Volume	10
Issue number	1
DOIs	https://doi.org/10.1186/s40959-024-00205-5
State	Published - Feb 6 2024
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cardiology and Cardiovascular Medicine

Access to Document

10.1186/s40959-024-00205-5

Fingerprint

Dive into the research topics of 'Correction to: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study (Cardio-Oncology, (2024), 10, 1, (3), 10.1186/s40959-023-00191-0)'. Together they form a unique fingerprint.

Cite this

Chu, J., Tung, L., Atallah, I., Wei, C., Cobleigh, M., Rao, R., Feinstein, S. B., Usha, L., Banach, K., Reiser, J., & Okwuosa, T. M. (2024). Correction to: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study (Cardio-Oncology, (2024), 10, 1, (3), 10.1186/s40959-023-00191-0). Cardio-Oncology, 10(1), 5. https://doi.org/10.1186/s40959-024-00205-5

Correction to: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study (Cardio-Oncology, (2024), 10, 1, (3), 10.1186/s40959-023-00191-0). / Chu, Jian; Tung, Lillian; Atallah, Issam et al.
In: Cardio-Oncology, Vol. 10, No. 1, 06.02.2024, p. 5.

Research output: Contribution to journal › Comment/debate › peer-review

Chu, J, Tung, L, Atallah, I, Wei, C, Cobleigh, M, Rao, R, Feinstein, SB, Usha, L, Banach, K, Reiser, J & Okwuosa, TM 2024, 'Correction to: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study (Cardio-Oncology, (2024), 10, 1, (3), 10.1186/s40959-023-00191-0)', Cardio-Oncology, vol. 10, no. 1, pp. 5. https://doi.org/10.1186/s40959-024-00205-5

@article{cb041b5b36384f13a7e22ece537d1116,

title = "Correction to: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study (Cardio-Oncology, (2024), 10, 1, (3), 10.1186/s40959-023-00191-0)",

abstract = "BioMed Central 1 5 0 2024 BioMed Central Ltd., part of Springer Nature 2024 No Unnumbered 2024 1 25 0 0 Regular ArchiveJournal Unnumbered OpenChoice OpenAccess OpenAccess OpenAccess OpenAccess OpenAccess OpenAccess false BodyRef/PDF/40959\_2024\_Article\_205.pdf All Typeset OnlinePDF Regular Erratum Medicine \& Public Health Oncology Cardiology Medicine true Following publication of the original article [1], the authors identified an error in the author name of Issam Atallah. The incorrect author name is: Issam Attalah. The correct author name is: Issam Atallah. The author group has been updated above and the original article [1] has been corrected.",

author = "Jian Chu and Lillian Tung and Issam Atallah and Changli Wei and Melody Cobleigh and Ruta Rao and Feinstein, \{Steven B.\} and Lydia Usha and Kathrin Banach and Jochen Reiser and Okwuosa, \{Tochukwu M.\}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = feb,

day = "6",

doi = "10.1186/s40959-024-00205-5",

language = "English (US)",

volume = "10",

pages = "5",

journal = "Cardio-Oncology",

issn = "2057-3804",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Correction to

T2 - Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study (Cardio-Oncology, (2024), 10, 1, (3), 10.1186/s40959-023-00191-0)

AU - Chu, Jian

AU - Tung, Lillian

AU - Atallah, Issam

AU - Wei, Changli

AU - Cobleigh, Melody

AU - Rao, Ruta

AU - Feinstein, Steven B.

AU - Usha, Lydia

AU - Banach, Kathrin

AU - Reiser, Jochen

AU - Okwuosa, Tochukwu M.

PY - 2024/2/6

Y1 - 2024/2/6

N2 - BioMed Central 1 5 0 2024 BioMed Central Ltd., part of Springer Nature 2024 No Unnumbered 2024 1 25 0 0 Regular ArchiveJournal Unnumbered OpenChoice OpenAccess OpenAccess OpenAccess OpenAccess OpenAccess OpenAccess false BodyRef/PDF/40959_2024_Article_205.pdf All Typeset OnlinePDF Regular Erratum Medicine & Public Health Oncology Cardiology Medicine true Following publication of the original article [1], the authors identified an error in the author name of Issam Atallah. The incorrect author name is: Issam Attalah. The correct author name is: Issam Atallah. The author group has been updated above and the original article [1] has been corrected.

AB - BioMed Central 1 5 0 2024 BioMed Central Ltd., part of Springer Nature 2024 No Unnumbered 2024 1 25 0 0 Regular ArchiveJournal Unnumbered OpenChoice OpenAccess OpenAccess OpenAccess OpenAccess OpenAccess OpenAccess false BodyRef/PDF/40959_2024_Article_205.pdf All Typeset OnlinePDF Regular Erratum Medicine & Public Health Oncology Cardiology Medicine true Following publication of the original article [1], the authors identified an error in the author name of Issam Atallah. The incorrect author name is: Issam Attalah. The correct author name is: Issam Atallah. The author group has been updated above and the original article [1] has been corrected.

UR - https://www.scopus.com/pages/publications/85184149148

UR - https://www.scopus.com/pages/publications/85184149148#tab=citedBy

U2 - 10.1186/s40959-024-00205-5

DO - 10.1186/s40959-024-00205-5

M3 - Comment/debate

C2 - 38321512

AN - SCOPUS:85184149148

SN - 2057-3804

VL - 10

SP - 5

JO - Cardio-Oncology

JF - Cardio-Oncology

IS - 1

ER -

Correction to: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study (Cardio-Oncology, (2024), 10, 1, (3), 10.1186/s40959-023-00191-0)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this